Discovery, with purpose:Â Reshaping R&D for the future
Former Novo Nordisk CSO Marcus Schindler shares insights on pharma R&D, scientific innovation, AI integration and global talent development...

Register for IbyIMD+ to continue reading this article
CHF 18 / per month or CHF 120 per year
IbyIMD+ Subscribe
Already a subscriber? Log in
Explore first person business intelligence from top minds curated for a global executive audience